The award will recognise innovations that launch a business or give it a big boost. It should be an original idea that is core to the busin...

Looking at what happens in the short term is important, as it does have an impact on stock prices. But also always keep an eye on the macro...

Pershad, who has been investing in Indian equities for nearly three decades, believes investors need to look beyond short-term market noise...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

The ET Health Conclave 2026 celebrated healthcare professionals and institutions. Leaders shared insights on healthcare infrastructure and ...

From AI-powered hospitals and genomics to regenerative medicine and precision cardiology, ET Health Conclave 2026 brought together India's ...

Andhra Pradesh signed an MoU with AstraZeneca for an integrated precision oncology ecosystem. This initiative will integrate artificial int...

India's pharma and healthcare sector recorded 65 deals worth $13.9 billion in Q2 CY2026, with volumes falling 17% quarter-on-quarter to a f...

South Korea's Seoul Semiconductor is planning a manufacturing foray in India. This and more in today's ETtech Top 5.

Artificial intelligence is often hailed as a game changer, but too many firms discover that their bold AI pilots collapse when their operat...

A Bengaluru newborn diagnosed with a rare and aggressive cancer faced the possibility of losing her hand just weeks after birth. A team of ...

Global private equity firms are expanding beyond hospitals into India's broader healthcare ecosystem, with Warburg Pincus, TA Associates, B...

Healthcare Global Enterprises is using artificial intelligence and patient data. Algorithms are being developed to personalise cancer treat...

Zydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through ...

The launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced ...

A gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...

Novartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision...